Arcellx, Inc. Share Price
Stocks
ACLX
US03940C1009
Biotechnology & Medical Research
|
Delayed
Nasdaq
01:30:00 28/04/2026 am IST
|
5-day change | 1st Jan Change | ||
| 115.07 USD | +0.03% |
|
-.--% | +76.49% |
| 08/05 | Gilead Sciences Expects Loss This Year on Acquired R&D Expenses | DJ |
| 08/05 | Gilead raises 2026 sales forecast, flags profit hit from acquisitions | RE |
| Market Cap | 675.14Cr 599.66Cr 560.79Cr 511.03Cr 962.09Cr 65TCr 975.31Cr 6.78TCr 2.63TCr 33TCr 2.53TCr 2.48TCr 1,06300Cr | P/E 2024 |
-38.3x | P/E 2025 | -16x |
|---|---|---|---|---|---|
| Enterprise Value | 628.33Cr 558.08Cr 521.9Cr 475.6Cr 895.38Cr 60TCr 907.69Cr 6.31TCr 2.44TCr 31TCr 2.36TCr 2.31TCr 99TCr | EV / Sales 2024 |
3,31,25,319x | EV / Sales 2025 | 14,81,61,186x |
| Free-Float |
88.44% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Arcellx, Inc.
| 1 day | +0.03% | ||
| 6 months | +0.22% | ||
| Current year | +76.49% |
| Current year | 60.36 |  | 115.13 |
| 1 year | 60.36 | | 115.13 |
| 3 years | 30.88 | | 115.13 |
| 5 years | 6.04 | | 115.13 |
| 10 years | 6.04 | | 115.13 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 28/04/26 | Tender | Director | 2,16,666 | 0.3705% | ||
| 28/04/26 | Tender | Chief Executive Officer | 56,03,097 | 9.5813% | ||
| 28/04/26 | Issuer sale | Director | 76,234 | 0.1304% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.03% | -.--% | +40.16% | +220.71% | 675.14Cr | |
| +4.16% | -0.36% | +49.37% | +94.17% | 7.45TCr | |
| -0.61% | +0.81% | +27.25% | +80.21% | 6.01TCr | |
| -2.54% | -1.65% | +4.86% | +33.32% | 4.82TCr | |
| -2.80% | -4.81% | +28.47% | +35.03% | 4.43TCr | |
| +0.90% | +3.72% | +352.03% | +692.13% | 4.4TCr | |
| -1.76% | +0.06% | +7.47% | +101.79% | 4.16TCr | |
| +3.32% | +3.49% | +11.18% | +51.23% | 3TCr | |
| +4.77% | +6.16% | +36.77% | +22.78% | 2.93TCr | |
| -3.67% | -9.62% | -25.41% | +333.01% | 2.49TCr | |
| Average | +0.17% | +1.78% | +53.21% | +166.44% | 4.04TCr | |
| Weighted average by Cap. | +0.35% | +1.80% | +58.62% | +152.82% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 107.94 95.87 89.65 81.7 153.81 10.39T 155.92 1.08T 419.86 5.29T 405.25 396.46 17T | 22.29 19.79 18.51 16.87 31.76 2.15T 32.19 223.94 86.69 1.09T 83.67 81.86 3.51T |
| Net income | -11Cr -9.53Cr -8.92Cr -8.13Cr -15Cr -1.03TCr -16Cr -107.87Cr -42Cr -526.37Cr -40Cr -39Cr -1.69TCr | -23Cr -20Cr -19Cr -17Cr -33Cr -2.2TCr -33Cr -230.04Cr -89Cr -1.12TCr -86Cr -84Cr -3.61TCr |
| Net Debt | -57Cr -51Cr -47Cr -43Cr -81Cr -5.5TCr -83Cr -574.34Cr -222.34Cr -2.8TCr -214.6Cr -209.94Cr -9TCr | -47Cr -42Cr -39Cr -35Cr -67Cr -4.51TCr -68Cr -470.4Cr -182.1Cr -2.3TCr -175.76Cr -171.95Cr -7.37TCr |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- ACLX Stock
Select your edition
All financial news and data tailored to specific country editions
